Updated:
Principia Biopharma Inc.
Principia Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001510487, and its reported...
Overview
Principia Biopharma Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001510487, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-10, it reported annual revenue of USD 35,160,000; total assets of USD 382,736,000 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Principia Biopharma Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001510487
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2019USD | $35.2M | — | $382.7M | $39.5M | -$42.5M | |
| FY2018USD | $69.1M | $18.2M | $195.5M | $34.5M | -$21.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| SC 13D | — | THE SCHEDULE 13D | |
| SC 13G | — | THE SCHEDULE 13G | |
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Principia Biopharma Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.